
Peter Joseph Leary MD PhD
Pulmonary Vascular Medicine
Professor of Medicine and Epidemiology (Adjunct) at the University of Washington
Join to view full profile
1959 Ne Pacific StSeattle, WA 98195
Phone+1 206-598-4615
Fax+1 206-598-3036
Dr. Leary is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Peter Leary is the Director of the Pulmonary Vascular Disease Program at the University of Washington, a board-certified pulmonologist, and a Professor of Medicine and Epidemiology. His grant funded research program is focused on identifying and targeting mechanisms that contribute to pulmonary hypertension and heart failure.
Education & Training
University of Washington School of Public HealthPhD, Epidemiology, 2013 - 2018
University of Washington School of Public HealthMS, Epidemiology , 2010 - 2013
University of WashingtonFellowship, Pulmonary Disease and Critical Care Medicine, 2009 - 2012
Johns Hopkins UniversityResidency, Internal Medicine, 2005 - 2009
Johns Hopkins University School of MedicineClass of 2005
Certifications & Licensure
WA State Medical License 2009 - 2028
American Board of Internal Medicine Pulmonary Disease
National Board of Physicians and Surgeons Critical Care Medicine
National Board of Physicians and Surgeons Internal Medicine
National Board of Physicians and Surgeons Pulmonary Disease
Clinical Trials
- Beraprost-314d Added-on to Tyvaso® (BEAT) Start of enrollment: 2013 May 31
- OPsumit USers Registry Start of enrollment: 2014 Apr 30
- U.S. CTEPH Registry
Publications & Presentations
PubMed
- Vascular compliance phenotyping in pulmonary arterial hypertension (a PVDOMICS study).Talitha G Wilson, Laura Oppegard, Hongyang Pi, Brian A Houston, W H Wilson Tang
JHLT Open. 2026-08-01 - Altitude-Associated Hemodynamic Alterations: Analysis from the Veterans Affairs Clinical Assessment, Reporting, and Tracking.Brian A Houston, Suman Kundu, Jonah Garry, Mathew Freiberg, Peter J Leary
Annals of the American Thoracic Society. 2026-07-14 - Corrigendum to 'The landscape of referrals for lung transplantation in pulmonary arterial hypertension: A report from the Pulmonary Hypertension Association Registry'[...Nicholas A Kolaitis, Jonathan P Singer, Sonja Bartolome, Murali M Chakinala, Daniel Grinnan
The Journal of Heart and Lung Transplantation. 2026-06-01
Press Mentions
6-Part Special Podcast Series Aims to Raise Awareness of Meth-PAHSeptember 15th, 2025
Discover CircResFebruary 16th, 2023
COVID Vaccine for Patient with Rare Disease? Best Guess Is YesJanuary 21st, 2021
Grant Support
- REVAMP-PH: REpurposing Valsartan May Protect against Pulmonary HypertensionUNIVERSITY OF WASHINGTON2023–2028
- The Pulmonary Hypertension- Multi-Dimensional Omics to Characterize Right Heart Adaptation (PH-MOCHA) studyUNIVERSITY OF WASHINGTON2020–2025
Professional Memberships
- Member
- Member
- Pulmonary Hypertension Association - PHAMember
- Pulmonary Vascular Research Institute - PVRIMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:








